A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)
Public ClinicalTrials.gov record NCT05001282. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Dose Escalation and Expansion Clinical Study to Evaluate the Safety and Efficacy of ELU001 in Subjects Who Have Advanced, Recurrent or Refractory FRα Overexpressing Tumors
Study identification
- NCT ID
- NCT05001282
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Elucida Oncology
- Industry
- Enrollment
- 79 participants
Conditions and interventions
Conditions
- Endometrial Adenocarcinoma
- Endometrial Cancer
- Endometrial Cancer Recurrent
- Endometrial Carcinosarcoma
- Endometrial Clear Cell Adenocarcinoma
- Endometrial Diseases
- Endometrial Neoplasms
- Endometrioid Adenocarcinoma
- Endometrioid Tumor
- Fallopian Tube Cancer
- Ovarian Adenocarcinoma
- Ovarian Cancer
- Ovarian Cancer Recurrent
- Ovarian Cancer Stage
- Ovarian Carcinoma
- Ovarian Diseases
- Ovarian Epithelial Cancer
- Ovarian Neoplasm Epithelial
- Ovarian Neoplasms
- Ovarian Serous Adenocarcinoma
- Ovary Cancer
- Ovary Disease
- Ovary Metastasis
- Ovary Neoplasm
- Peritoneal Cancer
Interventions
- ELU001 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 12, 2021
- Primary completion
- Jun 6, 2024
- Completion
- Jun 6, 2024
- Last update posted
- Aug 6, 2024
2021 – 2024
United States locations
- U.S. sites
- 18
- U.S. states
- 14
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic - Phoenix, AZ | Phoenix | Arizona | 85054 | — |
| Providence Medical Foundation | Fullerton | California | 92835 | — |
| Mayo Clinic - Jacksonville, FL | Jacksonville | Florida | 32224 | — |
| D&H Cancer Research Center | Margate | Florida | 33063 | — |
| Sarah Cannon Research Institute at Florida Cancer Specialists | Orlando | Florida | 32827 | — |
| Hope and Healing Cancer Services | Hinsdale | Illinois | 60521 | — |
| OSF Saint Francis Medical Center | Peoria | Illinois | 61606 | — |
| Mayo Clinic - Rochester, MN | Rochester | Minnesota | 55905 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | — |
| Duke University Medical Center - Duke Cancer Institute | Durham | North Carolina | 27719 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Thomas Jefferson University, Sidney Kimmel Cancer Center | Philadelphia | Pennsylvania | 19107 | — |
| Women & Infants Hospital of Rhode Island | Providence | Rhode Island | 02905 | — |
| Avera Cancer Institute | Sioux Falls | South Dakota | 57105 | — |
| Sarah Cannon Research Institute at Tennessee Oncology | Nashville | Tennessee | 37203 | — |
| Mary Crowley Cancer Research | Dallas | Texas | 75230 | — |
| New Experimental Therapeutics of San Antonio (NEXT Oncology) | San Antonio | Texas | 78229 | — |
| Fred Hutchinson Cancer Center | Seattle | Washington | 98109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05001282, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 6, 2024 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05001282 live on ClinicalTrials.gov.